You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Latanoprost bunod

Showing 1 - 25 of 168
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glaucoma, Open-Angle Trial in New York (Latanoprost 0.005%, Latanoprost bunod 0.024%, Normal saline 0.9%)

Completed
Has Results
  • Glaucoma, Open-Angle
  • Latanoprost 0.005%
  • +3 more
  • New York, New York
    New York Eye and Ear Infirmary of Mount Sinai
Sep 1, 2021

Glaucoma Trial in United States (Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%)

Active, not recruiting
  • Glaucoma
  • Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%
  • Mission Hills, California
  • +20 more
Jan 6, 2023

Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)

Recruiting
  • Ocular Hypertension
  • Latanoprostene Bunod
  • Placebo
  • Rochester, Minnesota
    Bausch Site 001
Sep 29, 2022

Hypotrichosis Trial in Indian Wells (Latanoprost and Minoxidil)

Recruiting
  • Hypotrichosis
  • Latanoprost and Minoxidil
  • Indian Wells, California
    WellMax
Mar 17, 2023

Open Angle Glaucoma or Ocular Hypertension Trial in Shanghai (OPC-1085EL, 0.005% Latanoprost)

Recruiting
  • Open Angle Glaucoma or Ocular Hypertension
  • Shanghai, China
    Eye & ENT Hospital of Fudan University
Oct 14, 2022

Glaucoma, Ocular Hypertension Trial (Latanoprost eluting contact lens, Topical Latanoprost)

Not yet recruiting
  • Glaucoma
  • Ocular Hypertension
  • Latanoprost eluting contact lens
  • Topical Latanoprost
  • (no location specified)
Mar 15, 2022

Elevated Intraocular Pressure Trial in United States (Latanoprost ophthalmic solution, 0.005%, TC-002 latanoprost ophthalmic

Active, not recruiting
  • Elevated Intraocular Pressure
  • Latanoprost ophthalmic solution, 0.005%
  • TC-002 latanoprost ophthalmic solution, 0.005%
  • Garden Grove, California
  • +19 more
May 23, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (NCX 470 0.065%, NCX 470 0.1%, Latanoprost 0.005%)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • NCX 470 0.065% (initial phase of trial)
  • +4 more
  • Newport Beach, California
    Eye Research Foundation
Oct 20, 2022

Intraocular Pressure Trial in Rochester (BOL-303259-X, Latanoprost)

Completed
Has Results
  • Intraocular Pressure
  • Rochester, New York
    Bausch & Lomb, Inc
Jun 27, 2018

Vitiligo Trial in Qina (Latanoprost 0.005% Ophthalmic Solution, 5Fluorouracil)

Active, not recruiting
  • Vitiligo
  • Qinā, Qena Governorate, Egypt
    South Valley University
Aug 22, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, Latanoprost ophthalmic

Recruiting
  • Primary Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • Latanoprost ophthalmic solution 0.005%
  • Aichi, Japan
  • +42 more
Aug 9, 2022

Open Angle Glaucoma Trial in Australia (PA5108 Latanoprost FA SR Ocular Implant)

Recruiting
  • Open Angle Glaucoma
  • PA5108 Latanoprost FA SR Ocular Implant
  • Castle Hill, New South Wales, Australia
  • +9 more
Dec 22, 2022

Glaucoma, Open-Angle, Hypertension, Ocular Trial in Austin (NCX 470, Latanoprost 0.005%)

Completed
Has Results
  • Glaucoma, Open-Angle
  • Hypertension, Ocular
  • NCX 470
  • Latanoprost 0.005%
  • Austin, Texas
    Texan Eye
Nov 9, 2022

Effect of Drug Trial in Lagos (Latanoprost 0.005% Ophthalmic Solution)

Recruiting
  • Effect of Drug
  • Latanoprost 0.005% Ophthalmic Solution
  • Lagos, Lagos State, Nigeria
    Guinness Eye Centre. Lagos University Teaching Hospital.
Nov 1, 2022

OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension Trial in La Jolla (Latanoprostene bunod 0.024% QD, Timolol maleate 0.5%

Completed
  • OAG - Open-Angle Glaucoma
  • OHT - Ocular Hypertension
  • Latanoprostene bunod 0.024% QD
  • Timolol maleate 0.5% BID
  • La Jolla, California
    UCSD Shiley Eye Institute
Jul 2, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in Te Aro, Rotorua (100ng/day PA5346 Latanoprost FA SR Ocular Implant)

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • 100ng/day PA5346 Latanoprost FA SR Ocular Implant
  • Te Aro, Wellington, New Zealand
  • +1 more
Apr 10, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Netarsudil/Latanoprost 0.02%/0.005%, GANFORT®)

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Graz, Austria
  • +67 more
Jan 24, 2022

Lower Eyelid Steatoblepharon Trial in Newport Beach (POLAT-001, Placebo)

Recruiting
  • Lower Eyelid Steatoblepharon
  • Newport Beach, California
    Medical Associates, Inc.
Jun 29, 2023

Glaucoma, Open-Angle, Ocular Hypertension Trial in Milano, Pavia, Roma (tafluprost/timolol)

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Milano, Italy
  • +2 more
Mar 18, 2022

Ocular Surface in Primary Open Angle Glaucoma or Ocular

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
    • Valladolid, Spain
      IOBA
    Jan 28, 2022

    Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (NCX 470 0.1%, Latanoprost 0.005%)

    Recruiting
    • Open Angle Glaucoma
    • Ocular Hypertension
    • NCX 470 0.1%
    • Latanoprost 0.005%
    • Newport Beach, California
      Eye Research Foundation
    Apr 26, 2022

    Glaucoma, Ocular Hypertension Trial in Vienna (Preservative-free latanoprost 50µg/ml, Preserved latanoprost 0.005%)

    Recruiting
    • Glaucoma
    • Ocular Hypertension
    • Preservative-free latanoprost 50µg/ml
    • Preserved latanoprost 0.005%
    • Vienna, Austria
      Department of Clinical Pharmacology, Medical University of Vienn
    Apr 6, 2022

    Normal Tension Glaucoma Trial in Vestal (Netarsudil Ophthalmic, Bimatoprost Ophthalmic)

    Not yet recruiting
    • Normal Tension Glaucoma
    • Netarsudil Ophthalmic
    • Bimatoprost Ophthalmic
    • Vestal, New York
      Roberts Eyecare Associates
    Aug 5, 2021

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Canada, United States (Xalacom, Xalatan, Timolol)

    Completed
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Phoenix, Arizona
    • +54 more
    Feb 17, 2021

    Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)

    Completed
    • Open Angle Glaucoma
    • Ocular Hypertension
    • Birmingham, Alabama
    • +63 more
    Feb 17, 2021